BackAgile Therapeutics Overview

Agile Therapeutics Total Assets

Track Agile Therapeutics's total assets ($15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$14.96M
↑ 19.03% YoYΔ $2.39M vs prior year quarter

Peer trimmed avg / median

Loading

Agile Therapeutics Total Assets History

Loading

Agile Therapeutics vs. peers: Total Assets Comparison

Loading

Agile Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Agile Therapeutics (AGRX) FAQ

Agile Therapeutics (AGRX) currently reports a total assets of $15M as of June 2024. That compares with $13M in the prior-year period — up 19.0% year over year. Use the charts on this page to explore Agile Therapeutics's total assets history and peer comparisons.

Agile Therapeutics's total assets increased from $13M to $15M — a 19.0% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Agile Therapeutics reported $15M in total assets as of June 2024. That compares with $13M in the prior-year period — up 19.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Agile Therapeutics, and consider following AGRX for alerts when major investors trade the stock.

Agile Therapeutics is classified in the Healthcare sector. On total assets, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGRX with unrelated industries.